Ceftin (cefuroxime) for Lyme disease
Glaxo is now promoting Ceftin (cefuroxime) for Lyme disease. It's the first antibiotic to be officially approved for this use.
It's for patients with symptoms of EARLY Lyme disease...usually a rash and flu-like symptoms. These symptoms usually show up BEFORE antibodies are detectable on blood tests.
Prompt treatment usually prevents long-term complications.